Episode 163: Kevan Herold, MD, Yale and Matthias Von Herrath, MD, UCSD

episode

TheSugarScience Podcast- curating the scientific conversation in type 1 diabetes not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Isidore Bakanja: Episode Five 14 min · 25 Sep 2026 · The Saints

The power of giving & receiving advice 21 min · 25 Sep 2026 · It's Been a Minute

7 Day Ceasefire Iran Offer, Trump-Xi AI Rivalry, More 10 min · 25 Sep 2026 · Bloomberg News Now

#685 - Joey Diaz 1h 59m · 25 Sep 2026 · This Past Weekend w/ Theo Von

NPR News: 09-25-2026 1AM EDT 5 min · 25 Sep 2026 · NPR News Now

1AM ET 09/25/2026 Newscast 3 min · 25 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded28 Nov 2022

Publisherfeed.podbean.com ↗

Handlerec:2095024

Show notes

In this episode, Kevan Herold and Matthias Von Herrath join us to discuss opportunities for Teplizumab in the treatment of Type 1 diabetes. Ask the Expert is a ~30 minute digital cafe experience where scientists and grad students can meet and exchange with thought leaders in the field of type 1 diabetes. Link below to sign up for a seat in the cafe!

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in